For the latest openings visit the Careers section of our website CPL Biologicals launches Cadiflu-S,World`s First Virus Like Particle(VLP) Vaccine for Seasonal Influenza
The public at large is cautioned of fraudulent activities and false commitments using the name of Cadila.

News & Events

  • CPL Biologicals launches Cadiflu-S, World’s First Virus Like Particle (VLP) Vaccine for Seasonal Influenza Read More >>
Therapeutic segment: Anti TB
Active Ingredient: Rifampicin 200 mg, Isoniazid 300 mg Piperine 10 mg
Pack Details: 6 C

Risorine is world’s first boosted-Rifampicin containing fixed-dose combination. Risorine uses lower dose of Rifampicin (200 mg instead of 450 mg) but maintains the same efficacy. Addition of Piperine inhibits auto induction and maintains the same level throughout therapy. This is where it scores above the earlier modes of treatment of tuberculosis

Counterfeit Drugs: In case of any information on /or availability of counterfeit products... Read More © 2019 Cadila Pharmaceuticals all right reserved
Corporate identification No : U24231GJ1991PLC015132
Cadila Pharmaceuticals